COVID-19 update | In Maharashtra, new cases drop sharply to 6,436; 24 die, 18,423 recover

With these additions, the overall tally of COVID-19 cases rose to 78,10,136, while the death toll jumped to 1,43,098, the department said in a bulletin.

PTI

February 07, 2022 / 21:11 IST

Representative image: Reuters

Maharashtra on Monday recorded 6,436 new coronavirus cases, a steep fall of 3,230 from a day ago, and 24 fresh deaths linked to the infection, while 18,423 more patients recovered from the disease, the state health department said. With these additions, the overall tally of COVID-19 cases rose to 78,10,136, while the death toll jumped to 1,43,098, the department said in a bulletin.

As per the bulletin, the number of recovered cases in Maharashtra increased to 75,57,034 after 18,423 patients were discharged during the day, leaving the state with 1,06,059 active cases.On Sunday, the state had recorded 9,666 cases and 66 fatalities.

ALSO READ: India reports under 1 lakh COVID-19 cases first time in 31 days

According to the department, till date a total of 3,334 patients infected with the highly contagious variant Omicron have been detected in the state. Out of these, 2,023 patients have been discharged following a negative RT PCR test.The state's coronavirus fatality rate is 1.83 per cent, while the recovery rate is 96.76 per cent, it said.

Currently, 6,73,875 people are in home isolation and another 2,383 in institutional quarantine.With 1,00,124 coronavirus tests conducted in the last 24 hours, the number of samples examined so far in Maharashtra rose to 7,56,55,012, the bulletin said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show

COVID-19 update | In Maharashtra, new cases drop sharply to 6,436; 24 die, 18,423 recover

With these additions, the overall tally of COVID-19 cases rose to 78,10,136, while the death toll jumped to 1,43,098, the department said in a bulletin.

Related stories

Subscribe to Tech Newsletters

COVID-19 update | In Maharashtra, new cases drop sharply to 6,436; 24 die, 18,423 recover

With these additions, the overall tally of COVID-19 cases rose to 78,10,136, while the death toll jumped to 1,43,098, the department said in a bulletin.

Related stories

Subscribe to Tech Newsletters

Trending news